How Often Is Enhertu Dosed? A Guide to the Treatment Schedule
•
4 min read
Enhertu (fam-trastuzumab deruxtecan-nxki) is a targeted cancer therapy that is typically administered to patients in a standardized, three-week dosing cycle. This schedule is carefully managed by healthcare providers to ensure the medication's effectiveness while monitoring for any potential side effects.
